Upregulated N‐cadherin expression is associated with poor prognosis in epithelial‐derived solid tumours: A meta‐analysis

Upregulated N‐cadherin expression is associated with poor prognosis in epithelial‐derived... INTRODUCTIONAs a life‐threatening disease, cancer has increasingly been a heavy burden of healthcare system. The failure of cancer therapy and poor outcomes are mostly owing to the development of local invasion and distant metastasis. Activating of invasion and metastasis has been demonstrated as one of the most important hallmark capabilities of cancer. To date, researchers have paid tremendous attention to the biological behaviour of cancer cells, aiming at finding potential therapeutic targets.Invasion and metastasis are considered as complex processes involving detachment of cancer cell from primary tumour site and formation of new tumour foci in distant organs. Epithelial‐mesenchymal transition (EMT), a developmental regulatory programme, identified as transformed epithelial cells loss epithelial constraints and then acquire the abilities to invade, resist apoptosis and metastasis, which is believed to play a vital role in broadly regulating invasion and metastasis. Cadherins are a family of calcium‐dependent glycoproteins, which responsible for Ca2+‐dependent cell‐cell adhesions. Of the members of this family, N‐cadherin (neuronal cadherin or cadherin‐2), a transmembrane glycoprotein, which is normally expressed in neuroectodermal and mesenchymal‐derived tissues, plays crucial role in lots of processes, such as cell‐cell adhesion, embryogenesis, gastrulation, neurulation, migration and invasion. Today, N‐cadherin is regarded as a vital marker of http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Clinical Investigation Wiley

Upregulated N‐cadherin expression is associated with poor prognosis in epithelial‐derived solid tumours: A meta‐analysis

Loading next page...
 
/lp/wiley/upregulated-n-cadherin-expression-is-associated-with-poor-prognosis-in-N6ygrUJJa3
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
Copyright © 2018 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd
ISSN
0014-2972
eISSN
1365-2362
D.O.I.
10.1111/eci.12903
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONAs a life‐threatening disease, cancer has increasingly been a heavy burden of healthcare system. The failure of cancer therapy and poor outcomes are mostly owing to the development of local invasion and distant metastasis. Activating of invasion and metastasis has been demonstrated as one of the most important hallmark capabilities of cancer. To date, researchers have paid tremendous attention to the biological behaviour of cancer cells, aiming at finding potential therapeutic targets.Invasion and metastasis are considered as complex processes involving detachment of cancer cell from primary tumour site and formation of new tumour foci in distant organs. Epithelial‐mesenchymal transition (EMT), a developmental regulatory programme, identified as transformed epithelial cells loss epithelial constraints and then acquire the abilities to invade, resist apoptosis and metastasis, which is believed to play a vital role in broadly regulating invasion and metastasis. Cadherins are a family of calcium‐dependent glycoproteins, which responsible for Ca2+‐dependent cell‐cell adhesions. Of the members of this family, N‐cadherin (neuronal cadherin or cadherin‐2), a transmembrane glycoprotein, which is normally expressed in neuroectodermal and mesenchymal‐derived tissues, plays crucial role in lots of processes, such as cell‐cell adhesion, embryogenesis, gastrulation, neurulation, migration and invasion. Today, N‐cadherin is regarded as a vital marker of

Journal

European Journal of Clinical InvestigationWiley

Published: Jan 1, 2018

Keywords: ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off